identified TPT1 as a potential prognostic marker in breast cancer, emphasising its role in regulating the p53 signalling pathway and reprogramming tumour cell phenotypes, acting as a critical regulator of cancer stem cell function and tumour reversal. This evidence concerns the gene TPT1 and neoplasm.